Companies / Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc.

ESPRCIK 1434868ANN ARBOR, MIesperion.com ↗

Financials · FY2025

Revenue$403.13M
Net income$-22.68M
Total debt$140.0K
Cash$156.16M
Diluted EPS$-0.11
Shares outstanding257.4M

Ownership

257.4M shares outstanding · as of Apr 30, 2026
1.2%Insiders
Ownership
Insiders1.22%3,148,977
10%+ / strategic8.15%20,975,620
Institutions63.79%164,211,370
Public float26.84%69,095,975

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Koenig Sheldon L.CEOPresident and CEO · Director
0.84%2,172,699
Halladay BenjaminChief Financial Officer
0.28%713,602
Looker BenjaminFormerChief Legal Officer
0.26%679,348
Carroll J MartinDirector
0.07%177,523
Hoffman Robert E.Director
0.03%85,153

Institutional holders 202

View all →
HolderValue% of shares
BlackRock, Inc.$69.92M8.60%
Vanguard Group Inc$55.30M5.81%
Two Seas Capital LP$44.04M4.62%
Wasatch Advisors LP$34.95M3.67%
Orbimed Advisors LLC$28.96M4.11%
Two Sigma Investments, LP$25.92M3.67%
State Street Corporation$22.99M2.83%
Marshall Wace, LLP$19.39M2.75%
D. E. Shaw & Co., Inc.$17.92M2.54%
Geode Capital Management, LLC$16.32M2.31%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 17, 2026Koenig Sheldon L.
CEO
SellCommon Stock$69.5K-26K
-1.16%
2,172,699
0.84% of shares
low
Mar 17, 2026Halladay Benjamin
Executive
SellCommon Stock$17.4K-6K
-0.89%
713,602
0.28% of shares
low
Mar 17, 2026Looker Benjamin
Executive
SellCommon Stock$15.4K-6K
-0.83%
679,348
0.26% of shares
low
Jan 20, 2026Looker Benjamin
Executive
SellCommon Stock$4.9K-2K
-0.44%
384,216
0.15% of shares
low
May 28, 2026Carroll J Martin
Director
GrantCommon Stock$0+80K
+81.80%
177,523
0.07% of shares
low
May 28, 2026Hoffman Robert E.
Director
GrantCommon Stock$0+80K
+1512.75%
85,153
0.03% of shares
low
Mar 13, 2026Koenig Sheldon L.
CEO
GrantCommon Stock$0+724K
+49.08%
2,198,277
0.85% of shares
low
Mar 13, 2026Looker Benjamin
Executive
GrantCommon Stock$0+301K
+78.30%
685,056
0.27% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Glazer Capital, LLCPassive13G—20,975,620—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ESPR——29664W105—